Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Cytori Therapeutics reports total revenues of $14.7M for 2009

Cytori Therapeutics is reporting its financial results for the year ended December 31, 2009.

From Evident Corporation - Life Sciences 12 Mar 2010

Study shows experimental thyroid drug reduces cholesterol

An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine. An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance called Eprotirome in patients with high cholesterol.

12 Mar 2010

VisEn Medical introduces VivoTag 680 XL fluorescent dye for labeling biomolecules

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new VivoTag® 680 XL fluorescent dye for labeling biomolecules in a broad range of in vitro and in vivo imaging applications.

12 Mar 2010

Hamilton Health Sciences establishes new research facility

Hamilton's role as one of the world's leading centres in cardiac, vascular and stroke research was amplified today with the grand opening of the David Braley Cardiac, Vascular and Stroke Research Institute at the Hamilton General Hospital site of Hamilton Health Sciences.

12 Mar 2010

Following existing cholesterol-lowering target guidelines can prevent more heart disease-related incidents

Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online today (Thursday 11 March) in the European Heart Journal.

11 Mar 2010

Lotus Pharmaceuticals announces groundbreaking ceremony to construct new building complex in Beijing

Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China, reported the groundbreaking ceremony on March 9 to construct a new building complex on the grounds of its production facility in Beijing.

11 Mar 2010

Poor, minority adults with chronic kidney disease face increase risk of developing ESRD

Chronic kidney disease (CKD) afflicts a large number of younger minority adults receiving medical care in settings that serve the uninsured and underinsured (settings collectively known as the healthcare safety net). Poor, minority adults with moderate to severe CKD are also two to four times more likely to progress to kidney failure than non-Hispanic whites.

11 Mar 2010

Adherence to lipid-lowering guidelines may help reduce cardiovascular deaths

11 Mar 2010

Eureka Genomics announces closing of $3.7M private financing round

Eureka Genomics today announced the closing of a $3.7 million private financing round whose participants included private individuals and undisclosed angel investors. The proceeds will further discovery research aimed at identifying novel microorganisms associated with specific cancers and other important diseases, as well as help grow Eureka Genomics’ high-throughput sequencing and bioinformatics service business on a global basis.

11 Mar 2010

Small study shows eprotirome decreases LDL cholesterol

People whose "bad" cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar. 11, issue of the New England Journal of Medicine, Johns Hopkins and Swedish researchers say an experimental drug called eprotirome lowered cholesterol up to 32 percent in those already on statins, an effect equal to that expected from doubling the statin drug doses, without harmful side effects.

10 Mar 2010

DSPA's lurasidone NDA accepted for FDA review

Dainippon Sumitomo Pharma America, Inc., a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd., today announced that the U.S. Food and Drug Administration recently accepted for review the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia. The NDA was submitted to FDA on December 30, 2009 and will receive a standard review.

10 Mar 2010

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company’s novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.

10 Mar 2010

Bilateral oophorectomy may do more harm than good

Removal of the ovaries (bilateral oophorectomy) while performing a hysterectomy is common practice to prevent the subsequent development of ovarian cancer. This prophylactic procedure is performed in 55% of all U.S. women having a hysterectomy, or approximately 300,000 times each year. An article in the March/April issue of The Journal of Minimally Invasive Gynecology suggests that this procedure may do more harm than good.

10 Mar 2010

Study shows strawberries can provide immense health benefits

When it comes to eating healthy, most people know it's a good long-term choice, but what they may not know is that eating certain foods daily can provide immediate health benefits.

10 Mar 2010

Rush University Medical Center develops WISHFIT program to help pre-menopausal women reduce visceral fat

Under a $7.1 million grant from the National Institutes of Health, Rush University Medical Center is developing a novel program, called WISHFIT, to help pre-menopausal women reduce visceral fat through a sustained increase in physical activity and reduction in stress.

9 Mar 2010

Tracking kidney number is just as important as controlling cholesterol, say DNA physicians

It's a silent epidemic that affects millions of Americans. Chronic Kidney Disease (CKD) is a life-threatening illness that can often be treated successfully if found early, and can be detected at an early stage using simple, inexpensive blood and urine tests. As part of its 2010 World Kidney Day awareness program, the physicians of Dallas Nephrology Associates urge everyone to know and track their "kidney number."

9 Mar 2010

Researchers examine benefits of collaboration between family physicians and community pharmacists

A research team from the Laval Centre de sant- et de services sociaux, Universit- de Montr-al and McGill University Health Centre has examined the benefits of greater collaboration between family physicians and community pharmacists for select patients.

9 Mar 2010

Rcadia Medical Imaging receives CE Mark for COR Analyzer System

Rcadia Medical Imaging today announced that it has received a CE Mark for the COR Analyzer® System, its proprietary software that helps identify patients with significant CAD (Coronary Artery Disease) by a fully automatic analysis of coronary CT angiography (cCTA) studies. The CE Mark allows the company to market the system in the European Union and other countries that accept the CE Mark registration. The COR Analyzer is marketed in the U.S. under 510(k) clearance and Rcadia was named 2009 Best New Radiology Vendor by AuntMinnie.com.

8 Mar 2010

Acceptance of initial regulatory filings for BMS-PCSK9Rx triggers $6M milestone payment to Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.

8 Mar 2010

World Heart Federation to open WCC Scientific Sessions 2010 in Beijing, China

In 100 days the World Heart Federation, with the support of the Chinese Society of Cardiology and the Chinese Medical Association, will open the World Congress of Cardiology (WCC) Scientific Sessions 2010 in Beijing, China.

8 Mar 2010

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Cytori Therapeutics reports total revenues of $14.7M for 2009

Study shows experimental thyroid drug reduces cholesterol

VisEn Medical introduces VivoTag 680 XL fluorescent dye for labeling biomolecules

Hamilton Health Sciences establishes new research facility

Following existing cholesterol-lowering target guidelines can prevent more heart disease-related incidents

Lotus Pharmaceuticals announces groundbreaking ceremony to construct new building complex in Beijing

Poor, minority adults with chronic kidney disease face increase risk of developing ESRD

Adherence to lipid-lowering guidelines may help reduce cardiovascular deaths

Eureka Genomics announces closing of $3.7M private financing round

Small study shows eprotirome decreases LDL cholesterol

DSPA's lurasidone NDA accepted for FDA review

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

Bilateral oophorectomy may do more harm than good

Study shows strawberries can provide immense health benefits

Rush University Medical Center develops WISHFIT program to help pre-menopausal women reduce visceral fat

Tracking kidney number is just as important as controlling cholesterol, say DNA physicians

Researchers examine benefits of collaboration between family physicians and community pharmacists

Rcadia Medical Imaging receives CE Mark for COR Analyzer System

Acceptance of initial regulatory filings for BMS-PCSK9Rx triggers $6M milestone payment to Isis Pharmaceuticals

World Heart Federation to open WCC Scientific Sessions 2010 in Beijing, China

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in